Evidence map›Paper›PMID 36556075›Full record

ArticleJournal of clinical medicine2022

Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey.

Max Wagener, Jasper Boeddinghaus, Oliver Gaemperli, Lorenz Räber, Fabian Nietlispach, Pascal Meier, Olivier Muller, Daniel Weilenmann, Raban Jeger, Swiss Working Group Interventional Cardiology of the Swiss Society of Cardiology

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 3 countries.

Max WagenerDepartment of Cardiology, Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, 4031 Basel, Switzerland.ORCID 0000-0002-7970-8989
Jasper BoeddinghausDepartment of Cardiology, Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, 4031 Basel, Switzerland.
Oliver GaemperliDepartment of Cardiology, Heart Clinic Hirslanden, 8032 Zurich, Switzerland.
Lorenz RäberDepartment of Cardiology, Bern University Hospital, 3010 Bern, Switzerland.
Fabian NietlispachHeart Centre Im Park, Hirslanden Clinic Im Park, 8027 Zurich, Switzerland.
Pascal MeierCantonal Hospital Freiburg, 1752 Villars-sur-Glâne, Switzerland.
Olivier MullerDepartment of Cardiology, University Hospital Vaud, 1011 Lausanne, Switzerland.
Daniel WeilenmannCantonal Hospital St. Gallen, 9007 St. Gallen, Switzerland.
Raban JegerDepartment of Cardiology, Triemli Hospital Zurich, 8063 Zurich, Switzerland.
Swiss Working Group Interventional Cardiology of the Swiss Society of Cardiology
University Hospital of Basel · CHHirslanden Klinik Im Park · CHKlinik Hirslanden · CHUniversity Hospital of Bern · CHUniversity of Basel · CHUniversity of Lausanne · CHUniversity of St.Gallen · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConsidering the global burden of cardiovascular disease, we analysed trends in interventional coronary and structural procedures over the past 16 years (2005-2021), using continuous data from the Swiss national registry.

methodsBased on a standardised questionnaire, data on coronary and structural interventions in Switzerland were assessed by the Working Group Interventional Cardiology of the Swiss Society of Cardiology (SSC). Here, we analysed the trend of annually performed interventions from 2005 to 2021 in Switzerland and the impact of the COVID-19 pandemic.

resultsWe observed a constant increase in the total number of cases (including coronary angiographies (CA) and percutaneous coronary interventions (PCI)) from 36,436 cases in 2005 to 56,555 cases in 2021 (+55%). With 18 cases in 2007, TAVI procedures have increased to 2004 cases in 2021. During the early phase of the COVID-19 pandemic in 2020, a slight decrease in CAs and PCIs of 9.15% was observed. In contrast, we did not observe an impact of the COVID-19 pandemic on the number of no TAVI procedures. Most importantly, all cause in-hospital mortality for coronary interventions before and during the peak of the COVID-19 pandemic was comparable (1.4% vs. 1.3%).

conclusionOver a 16-year period, we observed an upward trend in diagnostic and therapeutic procedures for coronary as well as structural heart disease, with only a small short-term impact of the COVID-19 pandemic on interventions and a similar procedure-related in-hospital-mortality in Switzerland.

Indexed as

COVID-19percutaneous coronary interventionstructural interventionSwitzerland

Identifiers

PMID36556075
PMCPMC9783484
OpenAlexW4312140390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.